Xu et al. found TBK1/IKKε inhibitors (TBK1/IKKε-Is) to be potent enhancers of β-cell regeneration in a zebrafish model of T1D, validated across mammalian systems including human and rat β-cells, and STZ-induced diabetic mice. Here, TBK1 is linked to type 1 diabetes mellitus.